CLINICAL_TRIALS
research
· 2025-11-19
Clinical Trial Update: Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment [Phase 2, Phase 3]
Summary
A Phase 2/3 trial is evaluating sildenafil to prevent and reduce cancer-related cognitive impairment; the study status indicates not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Cancer | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING